Article
Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.
Hepatology (Baltimore, Md.) - 1 Feb 1998
Melegari M, Scaglioni P P, Wands J R
Abstract excerpt
Hepatitis B virus (HBV) variant strains may develop during therapy for chronic infection with the nucleoside analog 2',3'-dideoxy-3'-thiacytidine (3TC). HBV mutants result from isoleucine (I) or valine (V) substitutions in the methionine (M) of the YMDD motif in the viral reverse-transcriptase catalytic domain. In addition, other mutations in the reverse-transcriptase "B domain" involving either a phenylalanine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
